A detailed history of O'Rourke & Company, Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, O'Rourke & Company, Inc holds 6,867 shares of MRK stock, worth $683,403. This represents 0.4% of its overall portfolio holdings.

Number of Shares
6,867
Previous 6,425 6.88%
Holding current value
$683,403
Previous $795,000 2.01%
% of portfolio
0.4%
Previous 0.45%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$111.15 - $128.97 $49,128 - $57,004
442 Added 6.88%
6,867 $779,000
Q2 2024

Jul 18, 2024

BUY
$123.8 - $132.96 $742 - $797
6 Added 0.09%
6,425 $795,000
Q1 2024

Apr 18, 2024

BUY
$113.24 - $131.95 $1,245 - $1,451
11 Added 0.17%
6,419 $847,000
Q4 2023

Jan 24, 2024

SELL
$100.18 - $109.02 $1,101 - $1,199
-11 Reduced 0.17%
6,408 $699,000
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $22,134 - $24,580
-215 Reduced 3.24%
6,419 $661,000
Q2 2023

Jul 25, 2023

BUY
$108.61 - $118.38 $3,801 - $4,143
35 Added 0.53%
6,634 $766,000
Q1 2023

May 12, 2023

BUY
$102.94 - $114.86 $1,235 - $1,378
12 Added 0.18%
6,599 $702,000
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $42,933 - $55,046
491 Added 8.05%
6,587 $731,000
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $21,555 - $24,214
255 Added 4.37%
6,096 $525,000
Q2 2022

Aug 12, 2022

SELL
$83.49 - $94.64 $58,109 - $65,869
-696 Reduced 10.65%
5,841 $533,000
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $32,417 - $36,338
441 Added 7.23%
6,537 $536,000
Q4 2021

Feb 16, 2022

BUY
$72.28 - $90.54 $440,618 - $551,931
6,096 New
6,096 $467,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track O'Rourke & Company, Inc Portfolio

Follow O'Rourke & Company, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Rourke & Company, Inc, based on Form 13F filings with the SEC.

News

Stay updated on O'Rourke & Company, Inc with notifications on news.